购物车里没有产品

Anti-c-Rel antibody

产品货号 产品 品牌 单位 存货 价格 促销价 数量  
AB-06-1153
Anti-c-Rel antibody
洱畔/Erpan Tech 有货

产品特性        

Product type: Primary antibody
Antigen: c-Rel
Immunogen: Recombinant protein
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:500); Immunoprecipitation; Immunohistochemistry (1:50-1:200)
Reactivity: Human
Clonality (clone number): Monoclonal (JM72-93)
Form: Liquid
Buffer: Tris-HCl buffer (pH7.4), 1% BSA, 40% glycerol, 0.05% NaN3.
Concentration: 1mg/ml
Purity: Protein A affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: Avian reticuloendotheliosis antibody
C REL antibody
C Rel protein antibody
c Rel proto oncogene protein antibody
Oncogene REL antibody
Oncogene REL avian reticuloendotheliosis antibody
Proto-oncogene c-Rel antibody
REL antibody
REL_HUMAN antibody
v rel avian reticuloendotheliosis viral oncogene homolog antibody
v rel reticuloendotheliosis viral oncogene homolog antibody
V rel reticuloendotheliosis viral oncogene homolog (avian) antibody
展开

靶向信息

Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator.

产品来源

洱畔科技实验室

文件下载

Material-Safety-Data-Sheet.pdf (下载55549 )